Methods Of Treating Fabry Disease In Patients Having A Mutation In The Gla Gene

Patent No. EP4114390 (titled "Methods Of Treating Fabry Disease In Patients Having A Mutation In The Gla Gene") was filed by Amicus Therapeutics on Mar 5, 2021. The application was issued on Dec 4, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
TEVA PHARMACEUTICALSSep 4, 2025D YOUNG
BRAND MURRAY FULLERSep 3, 2025BRAND MURRAY FULLER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP4114390

AMICUS THERAPEUTICS
Application Number
EP21715035A
Filing Date
Mar 5, 2021
Status
Granted And Under Opposition
Nov 1, 2024
Publication Date
Dec 4, 2024